FindTrial
Sign In

To compare the efficacy of two forms of parenteral iron preparations in the management of post partum anemia

Comparison of efficacy of two different preparation of injectable iron in the management of postpartum anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017699
Enrollment
200
Registered
2019-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R531- Weakness

Interventions

Intervention1: Iron isomaltoside: Patients between day 2 to day 7 post parturition will be included with hb between 6 to 9 gm/dl and serum ferritin less than 15microgram/dl.aCalculated dose iron sucr

Sponsors

Dr Rimpi Singla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Day 2 to 7 postpartum Hb between 6to 9gm / dl Serum ferritin Patients willing for follow up

Exclusion criteria

Exclusion criteria: Anemia in failure Acute maternal illness Pulmonary Edema History of allergy to injectable iron Bronchial asthma

Design outcomes

Primary

MeasureTime frame
Change in hb and red cell indicesTimepoint: 2 weeks and 6 weeks—

Secondary

MeasureTime frame
Change in clinical symptoms,quality of life ,fatigue scoreTimepoint: 2 weeks and 6 weeks—

Countries

India

Contacts

Public ContactDr Rimpi singla

PGIMER

shikha20vikas@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026